Nucleai Secured $6.5M Series-A Initial Closing Led by Debiopharm To Advance AI-Powered Precision Oncology Platform
TEL AVIV and LAUSANNE, Switzerland, July 7, 2020 /PRNewswire/ -- Nucleai (www.Nucleaimd.com), an Israeli start-up providing an artificial intelligence-powered precision oncology platform...